VICTORIA
The Australian Academy of Technology and Engineering (ATSE) and the Industry Mentoring Networking in STEM (IMNIS) invites you to join us for Engaging with Industry Victoria.
This event focuses on how, when and why researchers engage with industry, the importance of understanding commercialisation, milestones, timelines and budgets, developing strong professional connections beyond academia, as well as how developing an entrepreneurial mindset can facilitate resilience and success in any setting.
Keynote speaker Professor Andrew F Wilks FTSE FAHMS provide insights and learnings from throughout his career.
Following the Keynote presentation, a panel facilitated by Dr Joanna Newton, and including special guest panellists, Dr Rav Fernando, Melissa Wingard and Dr Anthony Filippis will share their experiences engaging with industry across all facets of the industry pipeline.
The IMNIS team is look forward to welcoming you all!
Event Details:
Wednesday 20th October, 8.00 - 9.00am Melbourne Time
To be held online, Zoom details will be sent upon registration.
KEYNOTE
Professor Andrew F Wilks FTSE FAHMS
Adjunct Professor, Monash University
Andrew Wilks is a serial entrepreneur with 25 years on the “dark side”, following a highly successful academic career as a cancer researcher at the Ludwig Institute for Cancer Research. He went on to found Cytopia (1997), one of Australia’s earliest ASX-listed drug discovery companies. Since then he has founded eleven companies in the drug discovery arena. He was co-founder of SYNthesis med chem, a global CRO with laboratories in China, and SYNthesis Research, a “venture-discovery” company that funds and manages drug discovery collaborations generated from academia.
Andrew holds an Adjunct Professorship at Monash University, and is an Honorary Enterprise Professor at the University of Melbourne. He is an elected Fellow of the Australian Academy of Technology and Engineering (ATSE) and of the Australian Academy of Health and Medical Sciences (AAHMS). He has received a number of awards including the JNJ Ausbiotech Industry Leadership Award, the ATSE Clunies Ross Medal, and the Lackmann Award for Translational Research.
FACILITATOR
Research Scientist, Agriculture Victoria
Passionate about research that delivers tangible benefits for farmers, since obtaining a PhD in animal breeding and genetics from the University of New England in 2016, Jo’s work has focused on practical tools to illustrate the benefit of better herd-improvement decisions on farm. This includes undertaking an Endeavour Postdoctoral Fellowship at Teagasc Moorepark, Ireland. Jo currently works as a research scientist for Agriculture Victoria on the DairyBio initiative.
Currently Deputy Chair of the Action for Agriculture Board, Jo has a history of active involvement across the wider agricultural sector, particularly in advocacy and support of young people in agriculture. This includes leadership roles across 14 not-for-profit organisations including Enactus Australia, NSW Farmers Association and Action for Agriculture.
Jo was awarded a Medal of the Order of Australia (OAM) in 2020 for her service to agriculture through her advocacy and support of young people, volunteering, and contribution to dairy research.
Panellists
Senior Consultant - Deloitte
Rav has a PhD in psychology from the University of Melbourne, specialising in attitude and behaviour change. She has 7+ years’ experience in data analytics, and has previously led a health technology start-up.
Rav is currently a Senior Consultant at Deloitte, where she helps clients develop and enhance their technology products and services. She is passionate about bringing science to life through innovative technologies.
Special Counsel - Phillips Ormonde Fitzpatrick
Melissa Wingard is a senior commercial technology lawyer, with over 17 years’ experience, assisting software, cybersecurity, and technology companies, across the Asia Pacific region, grow their business and meet strategic aims, whilst managing risk and regulatory compliance.
She has extensive experience in relation to commercialising intellectual property particularly in exploiting software, drafting and advising on various contractual arrangements, competition law, information security, data protection and privacy.
CEO & Managing Director Neurosciences Victoria Limited
Anthony is an internationally experienced senior leader with deep understanding and knowledge of the biotechnology, medical, pharmaceutical, healthcare and investment industries. He is currently the CEO & Managing Director of Neurosciences Victoria Limited, a company driving a collaborative neuroscience and mental health community to engage with governments and industry to translate research into health and commercial outcomes.
With over 20 years’ experience in business & corporate development, operations and senior management in ASX-listed and private companies, Anthony has developed strong commercial management and leadership skills through his Board of Directors, CEO, Executive Director, Vice President and Founder positions across these industries.
Agenda
| Wednesday 20th October, 2021 8.00 - 9.00am AEDT |
| Time | Activity |
| 8.00am | Welcome and Introduction Scott Cummins GAICD - IMNIS Program Manager, Australian Academy of Technology and Engineering |
| 8.05am | Keynote Address Professor Andrew F Wilks, FTSE FAHMS - Adjunct Professor, Monash University |
| 8.20am | Panel Discussion Facilitated by Dr Joanna Newton OAM - Research Scientist, Agriculture Victoria Dr Rav Fernando - Senior Consultant, Deloitte Melissa Wingard - Special Counsel, Phillips Ormonde Fitzpatrick Dr Anthony Filippis - CEO & Managing Director, Neurosciences Victoria Limited |
| 8.50am | Q & A Opportunity Facilitated by Scott Cummins GAICD |
| 8.55am | Closing Remarks Scott Cummins GAICD |
| 9.00am | Event Close |
Follow IMNIS on Social Media
| #IMNIS | #IMNIS2021 | #EngagingWithIndustry | #STEMCareers |